SCHEMBL2256603

SCHEMBL2256603

O=S(=O)(O)C(CCl)S(=O)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.32
CA5A P35218 1/20 0.31
CA5B Q9Y2D0 1/20 0.31
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2257854 0.75
SCHEMBL30538378 0.73
SCHEMBL27714617 0.71 CA1 (0.31) ALDH1A1TSHR
SCHEMBL3204454 0.71
SCHEMBL973895 0.71
SCHEMBL27694688 0.69 CA1 (0.30)
SCHEMBL4757103 0.69 TP53 (0.40) SLC22A6CA5ACA5B
SCHEMBL3381816 0.69
SCHEMBL10779913 0.69
SCHEMBL11318858 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399618-B2 High purity electrolytic sulfonic acid solutions ARKEMA INC. (US) 2016-07-26 US claimed
EP-1092790-B1 Electroplating of copper from alkanesulfonate electrolytes ARKEMA INC (US) 2013-07-31 EP claimed
US-20110198227-A1 HIGH PURITY ELECTROLYTIC SULFONIC ACID SOLUTIONS ARKEMA INC. (US) 2011-08-18 US claimed
US-7452486-B2 Zinc lanthanide sulfonic acid electrolytes ARKEMA INC. (US) 2008-11-18 US claimed
EP-1644558-A4 HIGH PURITY ELECTROLYTIC SULFONIC ACID SOLUTIONS ARKEMA INC (US) 2007-03-21 EP claimed
JP-2007506261-A 2007-03-15 JP claimed
US-20070051925-A1 Zinc lanthanide sulfonic acid electrolytes ARKEMA INC. 2007-03-08 US claimed
US-20060272950-A1 High purity electrolytic sulfonic acid solutions ARKEMA INC. 2006-12-07 US claimed
EP-1529126-A4 ELECTROLYTIC COPPER PLATING SOLUTIONS ATOFINA CHEM INC (US) 2006-07-05 EP claimed
EP-1644558-A1 HIGH PURITY ELECTROLYTIC SULFONIC ACID SOLUTIONS Arkema Inc. (US) 2006-04-12 EP claimed
WO-2004105051-A1 ZINC LANTHANIDE SULFONIC ACID ELECTROLYTES ARKEMA INC. (US) 2004-12-02 WO claimed
WO-2004101860-A1 HIGH PURITY ELECTROLYTIC SULFONIC ACID SOLUTIONS ARKEMA INC. (US) 2004-11-25 WO claimed
US-20040045832-A1 Methods for using the solutions and products formed by using such methods and solutions in which the solutions contain copper alkanesulfonate salts and free alkanesulfonic acids, wherein the free acid has a concentration from about 0.05 to ARKEMA INC. 2004-03-11 US claimed
WO-2004016829-A2 ELECTROLYTIC COPPER PLATING SOLUTIONS ATOFINA CHEMICALS, INC. (US) 2004-02-26 WO claimed
US-6605204-B1 Electrodeposition of metals onto electrical and electronic apparatus such as semiconductor substrates using acyclic sulfonic acids, esters and salts such as methanesulfonic acid; electrolysis ATOFINA CHEMICALS, INC. 2003-08-12 US claimed
EP-1092790-A2 Electroplating of copper from alkanesulfonate electrolytes Atofina Chemicals, Inc. (US) 2001-04-18 EP claimed
US-6048585-A PRECIPITATION WITH AN ALKALI METAL OR ALKALINE EARTH METAL CATION SUCH AS CALCIUM. ATOTECH DEUTSCHLAND GMBH (DE) 2000-04-11 US claimed
US-5944879-A ELECTROLESS NICKEL BATH ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-08-31 US claimed
CN-1208442-A Removal of phosphite ions from electroless nickel plating baths ATOTECH DEUTSCHLAND GMBH (DE) 1999-02-17 CN claimed
EP-0861924-A1 Hypophosphite solutions and their use in nickel plating ELF ATOCHEM NORTH AMERICA, INC. (US) 1998-09-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110198227-A1 HIGH PURITY ELECTROLYTIC SULFONIC ACID SOLUTIONS DSG1, STS, HCN2 SLC22A6 523/4885CA5A 2024/4885CA5B 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.